Warning: The NCBI web site requires JavaScript to function. more...
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.
Schwarzenbach H, Pantel K, Kemper B, Beeger C, Otterbach F, Kimmig R, Kasimir-Bauer S.
Breast Cancer Res. 2009;11(5):R71. Epub .
Related citations
A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer.
Schwarzenbach H, Müller V, Beeger C, Gottberg M, Stahmann N, Pantel K.
Breast Cancer Res. 2007;9(5):R66.
Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapy.
Kuhlmann JD, Schwarzenbach H, Otterbach F, Heubner M, Wimberger P, Worm KH, Kimmig R, Kasimir-Bauer S.
Genes Chromosomes Cancer. 2011 Aug;50(8):598-605. doi: 10.1002/gcc.20882. Epub 2011 May 11.
Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
Taback B, Giuliano AE, Hansen NM, Singer FR, Shu S, Hoon DS.
Cancer Res. 2003 Apr 15;63(8):1884-7.
Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.
Schwarzenbach H, Chun FK, Lange I, Carpenter S, Gottberg M, Erbersdobler A, Friedrich MG, Huland H, Pantel K.
Int J Cancer. 2007 Apr 1;120(7):1465-71.
Microsatellite alterations plasma DNA of primary breast cancer patients.
Shaw JA, Smith BM, Walsh T, Johnson S, Primrose L, Slade MJ, Walker RA, Coombes RC.
Clin Cancer Res. 2000 Mar;6(3):1119-24.
Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H, Müller V, Stahmann N, Pantel K.
Ann N Y Acad Sci. 2004 Jun;1022:25-32.
Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC, Vincent-Salomon A, Gomme S, Nos C, de Rycke Y, Thiery JP, Sigal-Zafrani B, Mignot L, Sastre-Garau X, Pierga JY; Institut Curie Breast Cancer Study Group.
Clin Cancer Res. 2008 Jun 1;14(11):3306-11.
Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
Wulf GG, Jürgens B, Liersch T, Gatzemeier W, Rauschecker H, Buske C, Hüfner M, Hiddemann W, Wörmann B.
J Cancer Res Clin Oncol. 1997;123(9):514-21.
Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
Schindlbeck C, Jeschke U, Schulze S, Karsten U, Janni W, Rack B, Sommer H, Friese K.
Histochem Cell Biol. 2005 Jun;123(6):631-7. Epub 2005 May 12.
A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).
Kasimir-Bauer S, Oberhoff C, Schindler AE, Seeber S.
Int J Oncol. 2002 May;20(5):1027-34. Review.
[Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T, Gatzemeier W, Scharnberg P, Jürgens B, Wörmann B, Becker H, Rauschecker HF, Hiddemann W, Wulf GG.
Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):277-80. German.
Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer.
Wiedswang G, Borgen E, Schirmer C, Kåresen R, Kvalheim G, Nesland JM, Naume B.
Int J Cancer. 2006 Apr 15;118(8):2013-9.
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.
Bidard FC, Vincent-Salomon A, Sigal-Zafrani B, Diéras V, Mathiot C, Mignot L, Thiery JP, Sastre-Garau X, Pierga JY.
Ann Oncol. 2008 Mar;19(3):496-500. Epub 2008 Jan 10.
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
Janni W, Rack B, Schindlbeck C, Strobl B, Rjosk D, Braun S, Sommer H, Pantel K, Gerber B, Friese K.
Cancer. 2005 Mar 1;103(5):884-91.
Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Schindlbeck C, Stellwagen J, Jeschke U, Karsten U, Rack B, Janni W, Jückstock J, Tulusan A, Sommer H, Friese K.
Clin Exp Metastasis. 2008;25(3):233-40. Epub 2008 Jan 10.
Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
Valladares-Ayerbes M, Iglesias-Díaz P, Díaz-Prado S, Ayude D, Medina V, Haz M, Reboredo M, Antolín S, Calvo L, Antón-Aparicio LM.
J Cancer Res Clin Oncol. 2009 Sep;135(9):1185-95. Epub 2009 Feb 17.
Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer.
Wang Q, Larson PS, Schlechter BL, Zahid N, Finnemore E, de las Morenas A, Blanchard RA, Rosenberg CL.
Int J Cancer. 2003 Oct 10;106(6):923-9.
Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.
Bidard FC, Vincent-Salomon A, Sigal-Zafrani B, Rodrigues M, Diéras V, Mignot L, Sastre-Garau X, Poupon MF, Pierga JY.
Clin Exp Metastasis. 2008;25(8):871-5. Epub 2008 Nov 7.
Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer.
Bidard FC, Kirova YM, Vincent-Salomon A, Alran S, de Rycke Y, Sigal-Zafrani B, Sastre-Garau X, Mignot L, Fourquet A, Pierga JY.
Ann Oncol. 2009 Nov;20(11):1836-41. Epub 2009 Jun 25.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on